ICCS e_Newsletter CSI Spring 2014 Suzanne Vercauteren MD, PhD, FRCPC Division of Hematopathology BC Children’s Hospital, Vancouver University of British.

Slides:



Advertisements
Similar presentations
CP Unknown Heme-10/19/2011 Kumaran Mudaliar and Girish Venkataraman
Advertisements

Hematopathology Lab December 12, Case 1 . Normal Peripheral Blood Smear.
Hematology RBC/WBC Case Studies
ICCS e-Newsletter CSI Spring 2014 Hong Lin, PhD and Cristina McLaughlin, MD APP-Unipath Denver, Colorado.
ICCS e-Newsletter CSI Fall 2014 UniPath - Denver, CO Richard Quinones, MLS (ASCP) Hong Lin, PhD Cristina McLaughlin, MD.
A 35 year old woman presents with increasing fatigue, lethargy, and muscle weakness. Her CBC reveals decreased numbers of erythrocytes, leukocytes, and.
General Hematology Slide Review. 15 month old with pallor and hemoglobin 2.5g/dl, MCV 62fl and retic 4% Drinks 48 oz of whole milk/day What is this child’s.
ECSI case Fall 2014 Andrea M. Sheehan, MD Associate Professor of Pathology & Immunology Baylor College of Medicine.
Lymphoid System Dr. Raid Jastania Dec, By the end of this session you should be able to: –Describe the components of the lymphoid system –List the.
Acute Leukaemia Dr. Soheir Adam, MRCPath Assistant Professor Department of Haematology, KAUH.
Various immunodeficiencies Hyperinflammatory but inadequate immune response Clinical picture of HLH.
Identification and Diagnosis of the Acute Leukemias
ICCS e-Newsletter CSI Winter 2013
Chapter 17 Chronic Leukemias.
Chronic Leukemia Dr. Rania Alhady Chronic Lymphocytic leukemia (CLL):
Lymphoma DR: Gehan Mohamed.
ICCS e-Newsletter CSI April 2014 Z. Jenny Mao, MT (ASCP) Timothy P. Singleton, MD Department of Laboratory Medicine and Pathology, University of Minnesota.
ICCS e-newsletter CSI Summer 2011 Jeannine T. Holden, MD Emory University School of Medicine Atlanta, GA.
O THER MALIGNANT LYMPHOPROLIFERATIVE DISORDERS The lymphomas and plasma cell problems.
Edward Camacho Mina 1061 MD4 WINDSOR UNIVERSITY HODGKIN LYMPHOMA.
ICCS e-Newsletter CSI Spring 2013 David A Westerman, MBBS FRACP FRCPA Department of Pathology Peter MacCallum Cancer Centre Melbourne, Australia.
Acute Myeloid Leukemias Diagnosis in The Light of WHO Revisions And Correlation With Risk Adaptive Management ; Case Discussions Dr. Rania Medhat Seliem.
Hemophagocytic Syndromes Maggie Davis Hovda Morning Report 10/30/2009.
Myeloproliferative Disorders (MPDs)
ICCS e-Newsletter CSI Fall 2010 David D. Grier, M.D. Department of Pathology. Wake Forest University.
4th Year Medical Student KAU
Red blood cell disorders / Anemia laboratory
Chronic leukemia 1. Chronic Lymphocytic leukemia (CLL) * Definition: Chronic neoplastic disorder characterized by accumulation of small mature-looking.
Lymphoma Rob Jones. Aim and learning outcomes Aim ◦ To revise the key points of lymphoma Learning outcomes ◦ Revise the basics of haemopoiesis ◦ Understand.
ZHIHONG HU, MD, PhD Fellow, Department of Hematopahtology
Case Presentation 31 year-old man with increased blast count
Future Directions in ALK Negative Anaplastic Large Cell Lymphoma
MLAB 1415: Hematology Keri Brophy-Martinez
1 CASE REPORT hematology Monika Csóka MD, PhD year old boy no abnormalities in previous anamnesis 2 weeks before viral infection (fever, coughing)
Case 297 Guilin Tang and Sa A. Wang Department of Hematopathology UT MD Anderson Cancer Center.
Case 255 Elizabeth Courville, MD Robert Hasserjian, MD Massachusetts General Hospital Society for Hematopathology/European Association for Haematopathology.
Asymptomatic lymphadenopathy Mediastinal mass Systemic symptoms Fever, Pruritus Other nonspecific symptoms and paraneoplastic syndromes Intra-abdominal.
Society for Hematopathology/European Association for Haematopathology 2013 Case Number 208 Erika Moore, MD; Darshan Roy, MD; Patti Cohen, MD; Adam Bagg,
SH/EAHP Workshop 2013 Case 93 Winnie Wu, M.D. Sheeja Pullarkat, M.D.
Case 316 Ryan Johnson, MD; Athena Cherry, PhD; Dita Gratzinger, MD, PhD Stanford University Medical Center SH-EAHP October 24, 2013.
CASE 411 Jose Gonzalez-Berjon, MD & Tariq Muzzafar, MD UT M.D. Anderson Cancer Center.
CP Case Conference Aplastic Anemia 1/27/12 Laura Walters.
ICCS e-Newsletter CSI Fall 2015 Hywyn R. O. Churchill, MD PhD Division of Hematopathology.
Patient history 70 year-old male with macrocytic anemia for 10 years, became transfusion dependent. Splenectomy for refractory anemia: 670gm B12, folate,
eCSI case Weijie Li, MD Department of Pathology & Laboratory Medicine
CASE OF THE MONTH Dr Narender Tejwani Consultant ( Hematopathologist)
Adam J. Wood, D.O. Rhett P. Ketterling, M.D. April E. Chiu, M.D.
Leishmaniasis Thomas Fourie MD M. Taher Shabani-Rad MD CLS, Division of Hematopathology.
Differential WBC Counting
eCSI case 2 – November 2016 Jyotinder Nain Punia, MD
CASE SUBMISSION 2016 EAHP BM Workshop
Acute myeloid leukemia
CLINICAL PROGRESSION INTRODUCTION METHOD CONCLUSION REFERENCES
ICCS e-Newsletter CSI Yao Schmidt, MD Department of Pathology
September 12th, 2011 Good Morning.
Case Western Reserve University and University Hospitals of Cleveland
18th Meeting of the European Association for Hematopathology
Figure 2 Percentage of CD19+/CD34+ cells with decreased CD81 median fluorescence intensity (MFI;
Early T-Cell Precursor ALL in 5 Year Old Female
ICCS e-newsletter CSI Sean R McMaster and George Deeb
by Rahul Matnani, and Karthik A. Ganapathi
Flow cytometric immunophenotyping for hematologic neoplasms
University of Vermont Medical Center
IMMUNOPHENOTYPING LEUKEMIAS AND LYMPHOMAS
by Elham Kamangar, and Weiqiang Zhao
Diagnostic Hematology
by Huifei Liu, and Shafinaz Hussein
Lymphoid Preponderance and the Absence of Basophilia
Leukemia case #9 Hello lovely girl وداد ابو رمضان حليمة نوفل
بسم الله الرحمن الرحیم.
Presentation transcript:

ICCS e_Newsletter CSI Spring 2014 Suzanne Vercauteren MD, PhD, FRCPC Division of Hematopathology BC Children’s Hospital, Vancouver University of British Columbia

e-CSI - Clinical History 4 year old boy with a 4 week history of unexplained fevers, massive hepatosplenomegaly, diffuse lymphadenopathy and bicytopenia Differential Diagnosis: – Infection – Lymphoma – Primary/Secondary Hemophagocytic lympho-histiocytosis (HLH)

e-CSI – Peripheral Blood CBCReference Range WBC: 14.4 x 10 9 /L( x 10 9 /L) RBC: 3.51 x /L( x /L) Hgb: 89 g/dL(105 – 135 g/dL) MCV: 76.9 fl(75.0 – 87.0 fl) RDW-CV: 0.149(0.117 – 0.157) Plts: 46 x 10 9 /L(200 – 490 x 10 9 /L) Differential CountReference Range Neutrophils: x 10 9 /L(1.50 – 8.50 x 10 9 /L) Lymphocytes: 3.29 x 10 9 /L(2.00 – 8.00 x 10 9 /L) Monocytes: 0.61 x 10 9 /L(0.00 – 0.90 x 10 9 /L) Eosinophils: 0.02 x 10 9 /L(0.00 – 0.50 x 10 9 /L) Basophils: 0.02 x 10 9 /L(0.00 – 0.20 x 10 9 /L)

e-CSI – Biochemistry ParameterValueNormal range ALT U/L AST U/L G GT U/L LDH U/L Ferritin11909 – 30 ug/L

Bone Marrow: – Normocellular marrow with trilineage hematopoiesis – Mild hemophagocytosis – Loose granulomas – CD20, CD3, CD4 and CD8 immunohistochemistry non contributory – Lymphoma screen panel ( see slide 18) by flow cytometry → normal Extensive infectious work up including TB as per patients recent travel to Cambodia e-CSI –Work-Up

Work up for HLH: – Fever present – Splenomegaly present – Cytopenias present – Ferritin ↑ ↑ – Triglycerides ↑ ↑ – Soluble IL-2 receptor ↑ ↑ – NK cell function → normal – Mild hemophagocytosis in BM → Criteria for HLH met (at least 5/8) e-CSI –Work-Up

Infectious work up continued: – Tuberculosis work up as granulomas seen in BM → pertinently negative – EBV and all other viruses → negative Work up for primary immune deficiency → Flow cytometric immunophenotyping on peripheral blood e-CSI –Work-Up

Acquisition: Beckman Coulter Navios flow cytometer Data analysis: Beckman Coulter Kaluza (software version 1.2) T+B cell panel on peripheral blood: e-CSI – Flowcytometric Studies FITCPC5RD1ECD Tube 1CD45CD3CD56CD19 Tube 2CD45CD3CD4CD8

e-CSI – Flowcytometric Studies Tube 1

e-CSI – Flowcytometric Studies Tube 2

This is strange!!!! (Repeat specimen showed same results) Aberrant CD3 dim-neg/CD4+/CD8+ population

Differential Diagnosis of aberrant T cell immunophenotype in this child: Hemophagocytic Lymphohistiocytosis (aberrant immunophenotype of CD8 + T cell (described) Pediatric T cell Lymphoma: T cell lymphoblastic Lymphoma Anaplastic Large Cell Lymphoma EBV positive T cell lymphoproliferative disorders of childhood e-CSI – Differential Diagnosis

Lymphoma panel on peripheral blood: e-CSI – Flowcytometric Studies PC5PEFITCECDPC7 Tube 1IgG1 Tube 2CD45CD4CD8CD20CD34 Tube 3CD45CD30CD25CD3CD5 Tube 4IgG1Cont PECont FITCIgG1 Tube 5CD45LambdaKappaCD10CD19 Tube 6IgG1cIgG1 IgG1 Tube 7CD45cCD79acTdTCD3CD19 cIgG1 = cytoplasmic IgG1

e-CSI – Flowcytometric Studies

Tube 2 Tube 3 ? some CD30, no CD25? Normal T cells CD4+/CD8+ e-CSI – Flowcytometric Studies

Tube 5 Tube 7 e-CSI – Flowcytometric Studies no TdT No B or T cells ? aberrant population

Blood specimen send for T and B cell clonality studies by PCR → CLONAL T cell population Lymph node biopsy suggested but surgeons wary about low platelet count (<20 x 10 9 /L at this time) e-CSI –Work-Up

Lymphoma screen panel on cells from supraclavicular cervical lymph node biopsy: e-CSI – Flowcytometric Studies PC5PEFITCECDPC7 Tube 1CD45IgG1 Tube 2CD45CD4CD8CD20CD2 Tube 3CD45LambdaKappaCD10CD19 Tube 4IgG1cIgG1 IgG1 Tube 5CD45cCD79acTdTCD3CD19

e-CSI – Flowcytometric Studies Lymph Node CD4+/CD8+ Bright CD2+

e-CSI – Flowcytometric Studies Lymph Node Dim CD3+

Sinus extended by large cells with convoluted nuclei Immunohistochemistry stains: – CD30 positive – ALK positive – CD3, CD4, CD8, CD68, CD1a and S100 negative – Brisk mitotic activity FISH shows NPM-ALK translocation e-CSI – Lymph Node Results

Aberrant T cell population detected in blood and lymph node but not bone marrow of this patient suggestive of mature T cell lymphoproliferative disorder CD3 expression on aberrant population in lymph node brighter compared to blood Immunohistochemistry studies differ from flow cytometry studies in that the aberrant cells are CD4 and CD8 negative by immunohistochemistry and CD30 positive in contrast to flow cytometry studies Circulating cells of this case of Anaplastic Large Cell Lymphoma were negative for CD30 and CD25 by flow cytometry (unfortunately these markers were not run on the lymph node) e-CSI – Case Conclusions

T cell lymphoblastic Lymphoma: 15% of childhood ALL BM always involved CD3+, CD2+, CD5+, CD7+, CD4 and CD8 often coexpressed BUT BONE MARROW NEGATIVE AND NO PERIPHERAL BLASTS SEEEN EBV positive T cell lymphoproliferative disorders of childhood: Mostly in Asia Sites of involvement: Liver, Spleen, LN, Bone marrow CD2+, CD3+, CD8+ (some CD4 and CD8 positive cases reported) BUT EBV serology NEGATIVE e-CSI – Pediatric T cell lymphomas

Anaplastic Large Cell Lymphoma 10-20% of childhood lymphomas Often advanced disease with B symptoms ALK+ in all pediatric cases CD3 often negative CD2, CD5 and CD4 often positive BUT almost always CD8 negative

Anaplastic Large Cell Lymphoma (ALCL) most common mature T-cell neoplasm in children and adolescents. approximately 15% of all non-Hodgkin lymphomas (NHL) in children and adolescents commonly present with advanced systemic disease nearly universally anaplastic large cell lymphoma kinase (ALK) positive event free survival (EFS) rates of 65-75% e-CSI – Pediatric ALCL

e-CSI – Flow Cytometric Findings in ALCL McCall CMMcCall CM et al. Am J Clin Pathol May;137(5):786-94Am J Clin Pathol. 15 cases of pediatric ALCL High forward and side scatter (monocyte or granulocyte region) Frequently expressed antigens: CD4 (85%), CD2 (77%), CD7 (62%), CD3 (54%) and CD5 (38%) CD3 often dimly expressed No CD8 expression!!!!!!

HLH is a hyperinflammatory syndrome Impaired cytotoxic T cells and NK cells Rare Primary (familial, inherited) and secondary (infection, hematological malignancy, rheumatological diseases) Often fatal Aberrant immunophenotype of T cells reported e-CSI – Hemophagocytic LymphoHistiocytosis

e-CSI – Flow Cytometric Findings in HLH McCall CMMcCall CM et al. Am J Clin Pathol May;137(5):786-94Am J Clin Pathol.

13/15 patients (87%) expressed activation marker HLA-DR on cytotoxic T cells 6/9 (67%)EBV associated HLH had aberrant expansion of CD8 + T cells with variable loss of CD3, CD5 and CD7 5/8 (63%) of non EBV associated HLH had expansion of CD8 + T cells but only one (familial HLH) had aberrant loss of markers CD3 or CD5 or CD7 → Care must be taken with diagnosing T cell lymphomas based on aberrant CD8 + T cells in the setting of HLH e-CSI – Flow Cytometric Findings in HLH

Aberrant CD8 + T cells are a common finding in HLH Therefore HLH can mask an underlying CD8 + T cell lymphoma Although rare, CD8 expression can be seen on ALCL e-CSI – Conclusions

References Pediatr Blood Cancer Nov;60(11): doi: /pbc Epub 2013 Jul 19. Pediatric subcutaneous panniculitis-like T-cell lymphoma with features of hemophagocytic syndrome.Merritt BY 1, Curry JL, Duvic M, Vega F, Sheehan AM, Curry CV. Pediatr Blood Cancer.Merritt BY Curry JLDuvic MVega FSheehan AMCurry CV Pediatr Hematol Oncol Sep;30(6): doi: / Epub 2013 Jun 12. Anaplastic large cell lymphoma in children and adolescents. Lowe EJ 1, Gross TG. Pediatr Hematol Oncol.Lowe EJGross TG Am J Clin Pathol May;137(5): Flow cytometric findings in hemophagocytic lymphohistiocytosis.McCall CM 1, Mudali S, Arceci RJ, Small D, Fuller S, Gocke CD, Vuica-Ross M, Burns KH, Borowitz MJ, Duffield AS. Am J Clin Pathol.McCall CMMudali SArceci RJSmall DFuller SGocke CDVuica-Ross MBurns KH Borowitz MJDuffield AS